NCT00623909

Brief Summary

The purpose of this study is to demonstrate the safety of the AvicennaTM class IV laser for application over the skin of human subjects. In addition, we seek to measure the effectiveness and utility of this class 4 laser therapy in the treatment of post-thoracotomy pain syndrome.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2008

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2008

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 14, 2008

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 26, 2008

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2008

Completed
Last Updated

February 7, 2017

Status Verified

February 1, 2017

Enrollment Period

11 months

First QC Date

February 14, 2008

Last Update Submit

February 3, 2017

Conditions

Keywords

Laser TherapyPost Thoracotomy PainAvicennaTM laser

Outcome Measures

Primary Outcomes (1)

  • The McGill pain questionnaire

    6 Treatments/6 Weeks

Secondary Outcomes (5)

  • The visual analog scale

    6 Weeks

  • An infrared thermometer will measure skin temperature before and after the treatment

    6 Treatments/6 Weeks

  • A 4-point Likert scale (none, mild, moderate, and severe) will be used to document skin redness.

    6 Treatments/6 Weeks

  • A 4-point Likert scale (none, mild, moderate, and severe) will be used to document skin tenderness

    6 Treatments/6 Weeks

  • At the end of the study patients will rate their satisfaction with the treatment using an 11 point Likert scale where 0 means completely dissatisfied and 10 means completely satisfied.

    6 Treatments/6 Weeks

Study Arms (1)

1

EXPERIMENTAL

To demonstrate the safety of the AvicennaTM class IV laser for application over the skin of human subjects. This study was terminated prior to subject enrollment and closed.

Device: AvicennaTM class IV laser application

Interventions

AvicennaTM class IV laser for application over the skin of human subjects in the treatment of post-thoracotomy pain syndrome. Six sessions, twenty minutes applications over a period of six weeks.

1

Eligibility Criteria

Age25 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women age 25-65 years old with chest wall pain after lung surgery lasting more than 2 months after surgery.
  • Subjects shall have failed conservative treatment which may include rest, physical therapy, braces, and over the counter anti-inflammatory medications. All those enrolled will be native English speakers and have at least a high school degree

You may not qualify if:

  • Subjects will be excluded if they are pregnant (which will be confirmed by a urine pregnancy test if they are of childbearing age)
  • Have previous history of other pain syndromes or psychiatric disorders.
  • We will exclude the morbidly obese (BMI \>30) because the laser may not be able to penetrate deep enough through adipose tissue. In addition, subjects who have had previous back surgery, or are on antidepressants for the treatment of depression in the preceding 6 weeks will be excluded as these may represent potential confounding factors.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Weill Cornell Medical College/New York Presbyterian Hospital

New York, New York, 10065, United States

Location

Study Officials

  • Edward Rubin, MD

    Weill Medical College of Cornell University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Not applicable, study terminated prior to enrollment and closed.
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 14, 2008

First Posted

February 26, 2008

Study Start

January 1, 2008

Primary Completion

December 1, 2008

Study Completion

December 1, 2008

Last Updated

February 7, 2017

Record last verified: 2017-02

Data Sharing

IPD Sharing
Will not share

Not Applicable, study terminated prior to enrollment and closed

Locations